{"id":293,"date":"2026-06-14T16:40:04","date_gmt":"2026-06-14T16:40:04","guid":{"rendered":"https:\/\/syrian-biomedica.com\/?page_id=293"},"modified":"2026-06-14T16:41:05","modified_gmt":"2026-06-14T16:41:05","slug":"mohamad-toutounji","status":"publish","type":"page","link":"https:\/\/syrian-biomedica.com\/ar\/mohamad-toutounji\/","title":{"rendered":"Dr. Mohamad Toutounji"},"content":{"rendered":"<h1>Dr. Mohamad Toutounji<\/h1>\n<div>\n<p>Dr. Mohamad Toutounji (Germany) Dr. Mohamad Toutounji is a specialized consultant in CMC and GMP Compliance, with more than ten years of hands-on experience leading pharmaceutical development projects from early laboratory research to full-scale commercial manufacturing.<\/p>\n<p><span style=\"font-weight: 400;\"><\/span><span style=\"font-weight: 400;\"> Dr. Toutounji supports pharmaceutical companies, emerging biotech firms, and contract development and manufacturing organizations (CDMOs) by designing integrated strategies that ensure product quality and regulatory compliance. His technical and scientific expertise spans a wide range of advanced therapeutic platforms, including:<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 Cell &amp; Gene Therapy<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 mRNA-based therapies and modern genetic technologies<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 Small Molecule development<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 Antibody\u2013Drug Conjugates (ADCs)<\/span><\/p>\n<\/div>\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2026\/01\/Dr.-Mohamad-Toutounji.jpg\" alt=\"\"><\/p>\n<div>\n<p><span style=\"font-weight: 400;\">Throughout his career, Dr. Toutounji has played a key role in:<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 Optimizing industrial processes and addressing development gaps<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 Leading technology transfer activities across research, clinical, and manufacturing stages<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 Building and enhancing quality systems and operational controls aligned with GMP standards<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">\u00a0 \u2022 Preparing regulatory submissions such as IND and IMPD, while guiding development teams toward complete compliance<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\"> Dr. Toutounji combines deep scientific knowledge in molecular biology and manufacturing technologies with practical experience in the pharmaceutical and MedTech industries, enabling him to deliver actionable and scalable solutions tailored to real-world production environments.<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\"> He also contributes to capability-building within scientific and operational teams through specialized training and strategic consulting. His work supports the development of modern, regulation-aligned pharmaceutical infrastructures\u2014particularly in regions working to advance their healthcare and manufacturing capabilities, such as Syria<\/span><\/p>\n<\/div>\n<p><!--more--><br \/>\n<!-- {\"type\":\"layout\",\"children\":[{\"name\":\"VCard\",\"type\":\"section\",\"props\":{\"animation\":\"slide-left-medium\",\"animation_delay\":\"200\",\"height\":\"viewport\",\"height_viewport_offset\":true,\"image_effect\":\"parallax\",\"image_parallax_bgx\":\"-300,-300\",\"image_parallax_bgy\":\"200,-150\",\"image_parallax_breakpoint\":\"m\",\"image_parallax_easing\":\"1\",\"image_position\":\"center-center\",\"media_visibility\":\"m\",\"style\":\"default\",\"title_breakpoint\":\"xl\",\"title_position\":\"top-left\",\"title_rotation\":\"left\",\"vertical_align\":\"middle\",\"width\":\"large\"},\"children\":[{\"type\":\"row\",\"props\":{\"column_gap\":\"large\",\"divider\":false,\"layout\":\"2-3,1-3\",\"row_gap\":\"large\"},\"children\":[{\"type\":\"column\",\"props\":{\"image_effect\":\"parallax\",\"image_parallax_easing\":\"1\",\"image_position\":\"top-left\",\"position_sticky_breakpoint\":\"m\",\"width_medium\":\"2-3\"},\"children\":[{\"type\":\"headline\",\"props\":{\"content\":\"Dr. Mohamad Toutounji\",\"image_align\":\"left\",\"image_margin\":\"xsmall\",\"margin_top\":\"remove\",\"text_align\":\"left\",\"title_element\":\"h1\",\"title_style\":\"heading-medium\"}},{\"type\":\"text\",\"props\":{\"column_breakpoint\":\"m\",\"content\":\"\n\n<p>Dr. Mohamad Toutounji (Germany) Dr. Mohamad Toutounji is a specialized consultant in CMC and GMP Compliance, with more than ten years of hands-on experience leading pharmaceutical development projects from early laboratory research to full-scale commercial manufacturing.<\\\/p>\\n\n\n<p><span style=\\\"font-weight: 400;\\\"><\\\/span><span style=\\\"font-weight: 400;\\\"> Dr. Toutounji supports pharmaceutical companies, emerging biotech firms, and contract development and manufacturing organizations (CDMOs) by designing integrated strategies that ensure product quality and regulatory compliance. His technical and scientific expertise spans a wide range of advanced therapeutic platforms, including:<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 Cell &amp; Gene Therapy<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 mRNA-based therapies and modern genetic technologies<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 Small Molecule development<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 Antibody\\u2013Drug Conjugates (ADCs)<\\\/span><\\\/p>\",\"margin\":\"default\",\"margin_bottom\":\"large\",\"margin_top\":\"large\",\"maxwidth\":\"2xlarge\",\"text_style\":\"large\"}}]},{\"type\":\"column\",\"props\":{\"image_position\":\"top-left\",\"image_width\":\"300\",\"media_overlay\":\"rgba(255, 255, 255, 0.54)\",\"position_sticky_breakpoint\":\"m\",\"vertical_align\":\"middle\",\"width_medium\":\"1-3\"},\"children\":[{\"type\":\"image\",\"props\":{\"image\":\"wp-content\\\/uploads\\\/2026\\\/01\\\/Dr.-Mohamad-Toutounji.jpg\",\"image_height\":\"700\",\"image_svg_color\":\"emphasis\",\"image_width\":\"600\",\"margin\":\"default\",\"text_align\":\"left\",\"text_align_breakpoint\":\"m\",\"text_align_fallback\":\"center\"}}]}]},{\"type\":\"row\",\"children\":[{\"type\":\"column\",\"props\":{\"image_position\":\"center-center\",\"position_sticky_breakpoint\":\"m\"},\"children\":[{\"type\":\"text\",\"props\":{\"column_breakpoint\":\"m\",\"content\":\"\n\n<p><span style=\\\"font-weight: 400;\\\">Throughout his career, Dr. Toutounji has played a key role in:<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 Optimizing industrial processes and addressing development gaps<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 Leading technology transfer activities across research, clinical, and manufacturing stages<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 Building and enhancing quality systems and operational controls aligned with GMP standards<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\">\\u00a0 \\u2022 Preparing regulatory submissions such as IND and IMPD, while guiding development teams toward complete compliance<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\"> Dr. Toutounji combines deep scientific knowledge in molecular biology and manufacturing technologies with practical experience in the pharmaceutical and MedTech industries, enabling him to deliver actionable and scalable solutions tailored to real-world production environments.<\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\"><br \\\/><\\\/span><span style=\\\"font-weight: 400;\\\"> He also contributes to capability-building within scientific and operational teams through specialized training and strategic consulting. His work supports the development of modern, regulation-aligned pharmaceutical infrastructures\\u2014particularly in regions working to advance their healthcare and manufacturing capabilities, such as Syria<\\\/span><\\\/p>\",\"margin\":\"default\",\"margin_bottom\":\"large\",\"margin_top\":\"large\",\"text_style\":\"large\"}}]}]}]}],\"version\":\"4.5.32\"} --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Mohamad Toutounji Dr. Mohamad Toutounji (Germany) Dr. Mohamad Toutounji is a specialized consultant in CMC and GMP Compliance, with more than ten years of hands-on experience leading pharmaceutical development projects from early laboratory research to full-scale commercial manufacturing. Dr. Toutounji supports pharmaceutical companies, emerging biotech firms, and contract development and manufacturing organizations (CDMOs) by [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-293","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/pages\/293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/comments?post=293"}],"version-history":[{"count":4,"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/pages\/293\/revisions"}],"predecessor-version":[{"id":297,"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/pages\/293\/revisions\/297"}],"wp:attachment":[{"href":"https:\/\/syrian-biomedica.com\/ar\/wp-json\/wp\/v2\/media?parent=293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}